BPCE
IOVA icon

Bank Pictet & Cie (Europe)’s Iovance Biotherapeutics IOVA Stock Holding History

Bank Pictet & Cie (Europe)’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,318
Closed -$158K – 197
2024
Q4 		$158K Buy
21,318
+1,950
+10% +$18.1K ﹤0.01% 163
2024
Q3 		$182K Sell
19,368
-23,605
-55% -$224K ﹤0.01% 151
2024
Q2 		$345K Sell
42,973
-10,917
-20% -$117K 0.01% 131
2024
Q1 		$799K Sell
53,890
-9,073
-14% -$106K 0.02% 115
2023
Q4 		$512K Buy
62,963
+19,239
+44% +$101K 0.02% 181
2023
Q3 		$199K Buy
43,724
+7,905
+22% +$51.6K 0.01% 251
2023
Q2 		$252K Sell
35,819
-2,146
-6% -$15.4K 0.01% 233
2023
Q1 		$232K Buy
37,965
+9,879
+35% +$68.2K 0.01% 166
2022
Q4 		$179K Buy
28,086
+410
+1% +$3.2K 0.01% 161
2022
Q3 		$265K Hold
27,676
– – 0.01% 149
2022
Q2 		$306K Sell
27,676
-206
-0.7% -$2.7K 0.01% 134
2022
Q1 		$464K Buy
27,882
+2,893
+12% +$44.7K 0.02% 128
2021
Q4 		$477K Buy
24,989
+2,927
+13% +$64.4K 0.02% 133
2021
Q3 		$544K Sell
22,062
-2,010
-8% -$47.4K 0.02% 128
2021
Q2 		$626K Buy
24,072
+17,575
+271% +$457K 0.02% 126
2021
Q1 		$206K Buy
+6,497
New +$269K 0.01% 172

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Bank Pictet & Cie (Europe)'s IOVA Position: Q1 2025 in Review

Bank Pictet & Cie (Europe) sold out of Iovance Biotherapeutics (IOVA) in Q1 2025, closing a stake of 21,318 shares — an estimated $158K sold.

Bank Pictet & Cie (Europe) first reported a position in IOVA in Q1 2021 and held it in 16 quarters. The position peaked at $799K in Q1 2024. 301 funds tracked by Wall St. Rank hold IOVA as of Q1 2025.

  • Bank Pictet & Cie (Europe) reported no remaining Iovance Biotherapeutics position as of Q1 2025 after selling out during the quarter.
  • Bank Pictet & Cie (Europe) sold 21,318 Iovance Biotherapeutics shares in Q1 2025, an estimated $158K.
  • Bank Pictet & Cie (Europe) first reported a position in Iovance Biotherapeutics in Q1 2021 and held it in 16 quarters.
  • Bank Pictet & Cie (Europe)'s Iovance Biotherapeutics position peaked at $799K in Q1 2024.
  • 301 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q1 2025.

Based on Bank Pictet & Cie (Europe)'s 13F filing for Q1 2025, filed 17 Apr 2025.